Free shipping on all orders over $ 500

CH 275

Cat. No. M54030

All AbMole products are for research use only, cannot be used for human consumption.

CH 275 Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

CH 275 is a peptide analog of somatostatin and binds preferably to somatostatin receptor 1 (sst1) with a Ki of 52 nM.

Chemical Information
Molecular Weight 1485.77
Formula C74H96N14O15S2
CAS Number 174688-78-9
Form Solid
Solubility (25°C) DMSO 90 mg/mL
Water 30 mg/mL
Storage -20°C, protect from light, dry, sealed
Related Somatostatin Receptor Products
Pasireotide

Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

Octreotide Acetate

Octreotide acetate(SMS 201995 acetate) is a long-acting octapeptide with pharmacologic actions mimicking those of the natural hormone somatostatin.

Cyclosomatostatin acetate

Cyclosomatostatin acetate is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin acetate can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells.

FK962

FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions.

Lanreotide

Lanreotide is a somatostatin analogue, acts as an inhibitor of growth hormone (GH).

  Catalog
Abmole Inhibitor Catalog




Keywords: CH 275 supplier, Somatostatin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.